News

This is some text inside of a div block.
August 27, 2025

eCLIPs Shows High Rate of Technical Success in Treating Aneurysm Recurrences in New Publication

A multicenter study published in the Journal of NeuroInterventional Surgery evaluates the next-generation eCLIPs device for retreatment of aneurysm recurrences following treatment with an intrasaccular device.

Read More
This is some text inside of a div block.
August 1, 2025

Evasc Neurovascular Reports Breakthrough Clinical Data and Launches New eCLIPs Flow Diverter Device Compatible with 0.021" Microcatheter

Evasc Neurovascular announces groundbreaking real-world clinical data confirming that eCLIPs provides durable, efficient, and safe treatment for WNBAs and new eCLIPs Flow Diverter...

Read More
This is some text inside of a div block.
June 29, 2022

Upcoming Conferences 2022

Evasc is pleased to be present at the following conferences and events in 2022. If you would like to set up a meeting to discuss your neurovascular requirements, please get in touch with us.

Read More
This is some text inside of a div block.
April 8, 2022

One year results from the European eCLIPs Safety, Feasibility, and Efficacy Study (EESIS)

We're excited to announce the 1 year results from the European eCLIPs Safety, Feasibility, and Efficacy Study (EESIS).

Read More
This is some text inside of a div block.
January 13, 2022

Enrollment of First Patient in the French eCLIPs Safety, Feasibility, and Efficacy Study (EESIS-FR)

We’re delighted to announce the enrolment of the first patient in Evasc Neurovascular’s French eCLIPs Safety, Feasibility, and Efficacy Study (EESIS-FR).

Read More
This is some text inside of a div block.
October 20, 2021

Evasc Neurovascular Announces the New eCLIPs Bifurcation Flow Diverter

Evasc Neurovascular is proud to announce the third generation of its eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter.

Read More
This is some text inside of a div block.
February 26, 2021

Evasc Neurovascular Announces First Neuro Product Approved in French Forfait Innovation Program

The eCLIPs device is the first neuro device that has gained Forfait Innovation approval and funding...

Read More
This is some text inside of a div block.
February 22, 2021

Evasc Announces the Appointment of Robert Greene to the Board of Directors

Robert was previously the Chief Technology Officer and Co-Founder at MicroVention Inc...

Read More
This is some text inside of a div block.
February 16, 2021

Measurements of the Flow-Diverting Effects of a New Generation of the eClips Implant

A new generation of eCLIPs implant, the eCLIPs bifurcation flow diverter (eBFD), with higher metal coverage showed similar reduction of flow in a bifurcation anatomy...

Read More
This is some text inside of a div block.
November 3, 2020

Evasc Announces the Appointment of Dr. Martin Rothman to the Board of Directors

Dr. Rothman is an experienced executive who brings his expertise as founder, Director and investor...

Read More
This is some text inside of a div block.
November 3, 2020

EVASC Announces CE Mark Approval for its new eCLIPs Bifurcation Remodelling System

Evasc announces that the new eCLIPs Bifurcation Remodeling System (eB) has been granted CE Mark approval...

Read More
This is some text inside of a div block.
September 8, 2020

Coil retention and flow diversion for the treatment of cerebral aneurysms

NeuroNews interviewed Dr. Leif Sorensen to get his clinical experience with the 1st generation eCLIPs bifurcation system...

Read More

Sign up for updates

Evasc Neurovascular Enterprises
Terms of UsePrivacy Policy

107-1099 West 8th Avenue
Vancouver, BC, Canada V6H 1C3
+1 (604) 742-3811

©2025 All rights reserved.
Designed to matter by Bemoved Media.